Age-dependent effects of modafinil on acoustic startle and prepulse inhibition in rats

Behavioural Brain Research
Sandra L McFaddenRussell E Morgan

Abstract

Modafinil is a psychostimulant approved for treating excessive sleepiness in adults; off-label uses (e.g., treatment of cognitive impairment in schizophrenia, ADHD and age-related dementias) are currently being explored. The effects and mechanisms of action of modafinil have not been fully established. In the present study, the effects of modafinil were examined in young adult (7-month-old) and middle-aged (21-22-month-old) rats, using the acoustic startle response (ASR) and prepulse inhibition (PPI). In the control condition, middle-aged rats showed lower activity levels, significantly lower ASR amplitudes and significantly longer ASR latencies compared to young adult rats. The effects of modafinil differed by age: activity levels and ASR amplitudes were significantly increased in middle-aged rats, whereas activity levels were lower and ASR amplitude was significantly decreased in young adult rats. Modafinil did not significantly alter PPI or startle latencies relative to the control condition. Amphetamine, used as a positive control, significantly decreased ASR amplitude in young adult rats and significantly impaired PPI for both age groups. Amphetamine-induced PPI impairment was greater for young adult rats (34% reduction in...Continue Reading

References

Dec 1, 1992·Synapse·J Day, H C Fibiger
Nov 1, 1987·Neurochemical Research·A MorettiF Trunzo
Jan 1, 1988·Psychopharmacology·R S MansbachD L Braff
Sep 15, 1983·Toxicology and Applied Pharmacology·L D Fechter, J S Young
Apr 1, 1981·Behavioral and Neural Biology·E E KrauterB A Campbell
Dec 20, 1993·Behavioural Brain Research·M DavisM Kim
Sep 1, 1993·Psychophysiology·M M BradleyP J Lang
Feb 25, 1998·Behavioural Brain Research·M Koch, H U Schnitzler
Jul 14, 1998·Neurobiology of Aging·G B VartyM A Geyer
Apr 20, 1999·Psychopharmacology·Z A MartinezN R Swerdlow
Jan 29, 2000·Journal of Neural Transmission·J M MíguezE Sánchez-Barceló
May 11, 2000·Psychopharmacology·J ZhangL Svensson
Jul 12, 2001·Psychophysiology·D SabatinelliP J Lang
Sep 11, 2001·Psychopharmacology·M FendtJ S Yeomans
Aug 2, 2002·Pharmacology, Biochemistry, and Behavior·Daniel BéracochéaChristophe Pierard
Mar 14, 2003·Biological Psychology·Joel EllwangerDavid L Braff
Jul 11, 2003·Biological Psychology·Katja LudewigFranz X Vollenweider
Dec 4, 2003·Pharmacology, Biochemistry, and Behavior·Daniel BéracochéaChristophe Pierard
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·Christopher P WardJohn G McCoy
Feb 25, 2005·Journal of Psychopharmacology·Kerry A WatersRebecca Dias
Mar 22, 2006·Psychopharmacology·Sanneke A M van VlietIngrid H C H M Philippens
May 4, 2006·The Journal of Clinical Psychiatry·Jacob S Ballon, David Feifel
Mar 3, 2007·Pharmacology, Biochemistry, and Behavior·Russell E MorganMarsha M Dopheide
Mar 8, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ebony R SamuelsChristopher M Bradshaw
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J Minzenberg, Cameron S Carter
Oct 16, 2007·Psychopharmacology·Daniel BéracochéaChristophe Piérard
Mar 4, 2009·Psychopharmacology·Ralf RegenthalUte Krügel

❮ Previous
Next ❯

Citations

Sep 18, 2012·Experimental Gerontology·Natalia RybalkoJosef Syka
Jun 1, 2012·Therapeutic Advances in Psychopharmacology·Laura Christina WittkampfMarike Lancel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.